ERBB2 and ductal breast carcinoma in situ: MRI additionally noted a small enhancing mass of the left breast, biopsy showing a concurrent grade 1 invasive ductal carcinoma with associated low-grade DCIS, ER >95%, PR 30%, HER2- (1+ IHC).